Aberrantly Expressed Non-Coding RNAs in the Placenta and Their Role in the Pathophysiology of Gestational Diabetes Mellitus

References

• Jovanovic L , Pettitt DJ . Gestational diabetes mellitus. JAMA . 2001;286(20):2516–2518. doi:10.1001/jama.286.20.2516 11722247
   PubMed Web of Science ®Google Scholar
• Cho NH , Shaw JE , Karuranga S , et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract . 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023 29496507
   PubMed Web of Science ®Google Scholar
• Lowe WL Jr. , Scholtens DM , Kuang A , et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care . 2019;42(3):372–380. doi:10.2337/dc18-1646 30655380
   PubMed Web of Science ®Google Scholar
• Maryns AS , Dehaene I , Page G . Maternal and neonatal outcomes in a treated versus non- treated cohort of women with gestational diabetes mellitus according to the HAPO 5 and 4 criteria. Facts Views Vis Obgyn . 2017;9(3):133–140.29479398
   PubMed Web of Science ®Google Scholar
• Gauster M , Desoye G , Totsch M , Hiden U . The placenta and gestational diabetes mellitus. Curr Diab Rep . 2012;12(1):16–23. doi:10.1007/s11892-011-0244-5 22102097
   PubMed Web of Science ®Google Scholar
• Kampmann U , Knorr S , Fuglsang J , Ovesen P . Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res . 2019;2019:5320156. doi:10.1155/2019/5320156 31828161
   PubMed Web of Science ®Google Scholar
• Fuglsang J , Sandager P , Moller N , Fisker S , Orskov H , Ovesen P . Kinetics and secretion of placental growth hormone around parturition. Eur J Endocrinol . 2006;154(3):449–457. doi:10.1530/eje.1.02109 16498059
   PubMed Web of Science ®Google Scholar
• Lonberg U , Damm P , Andersson AM , et al. Increase in maternal placental growth hormone during pregnancy and disappearance during parturition in normal and growth hormone-deficient pregnancies. Am J Obstet Gynecol . 2003;188(1):247–251. doi:10.1067/mob.2003.82 12548225
   PubMed Web of Science ®Google Scholar
• Roeder HA , Moore TR , Ramos GA . Changes in postpartum insulin requirements for patients with well-controlled type 1 diabetes. Am J Perinatol . 2016;33(7):683–687. doi:10.1055/s-0036-1571323 26862721
   PubMed Web of Science ®Google Scholar
• Carrasco-Wong I , Moller A , Giachini FR , et al. Placental structure in gestational diabetes mellitus. Biochim Biophys Acta Mol Basis Dis . 2020;1866(2):165535. doi:10.1016/j.bbadis.2019.165535 31442531
   PubMed Web of Science ®Google Scholar
• Beermann J , Piccoli MT , Viereck J , Thum T . Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev . 2016;96(4):1297–1325. doi:10.1152/physrev.00041.2015 27535639
   PubMed Web of Science ®Google Scholar
• Ha M , Kim VN . Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol . 2014;15(8):509–524.25027649
   PubMed Web of Science ®Google Scholar
• Tsagakis I , Douka K , Birds I , Aspden JL . Long non-coding RNAs in development and disease: conservation to mechanisms. J Pathol . 2020;250(5):480–495. doi:10.1002/path.5405 32100288
   PubMed Web of Science ®Google Scholar
• Kristensen LS , Andersen MS , Stagsted LVW , Ebbesen KK , Hansen TB , Kjems J . The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet . 2019;20(11):675–691. doi:10.1038/s41576-019-0158-7 31395983
   PubMed Web of Science ®Google Scholar
• Khalifa O , Errafii K , Al-Akl NS , Arredouani A . Noncoding RNAs in nonalcoholic fatty liver disease: potential diagnosis and prognosis biomarkers. Dis Markers . 2020;2020:8822859. doi:10.1155/2020/8822859 33133304
   PubMed Web of Science ®Google Scholar
• Fu G , Brkic J , Hayder H , Peng C . MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci . 2013;14(3):5519–5544. doi:10.3390/ijms14035519 23528856
   PubMed Web of Science ®Google Scholar
• Morales-Prieto DM , Chaiwangyen W , Ospina-Prieto S , et al. MicroRNA expression profiles of trophoblastic cells. Placenta . 2012;33(9):725–734. doi:10.1016/j.placenta.2012.05.009 22721760
   PubMed Web of Science ®Google Scholar
• Donker RB , Mouillet JF , Chu T , et al. The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod . 2012;18(8):417–424. doi:10.1093/molehr/gas013 22383544
   PubMed Web of Science ®Google Scholar
• Li Y , Zhuang J . miR-345-3p serves a protective role during gestational diabetes mellitus by targeting BAK1. Exp Ther Med . 2021;21(1):2.33235611
   PubMed Web of Science ®Google Scholar
• Zhang L , Li K , Tian S , et al. Down-regulation of microRNA-30d-5p is associated with gestational diabetes mellitus by targeting RAB8A. J Diabetes Complications . 2021;35(8):107959. doi:10.1016/j.jdiacomp.2021.107959 34052089
   PubMed Web of Science ®Google Scholar
• Tang L , Li P , Li L . Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus. J Diabetes Investig . 2020;11(5):1307–1317. doi:10.1111/jdi.13250
   PubMed Web of Science ®Google Scholar
• Li J , Song L , Zhou L , et al. A microRNA signature in gestational diabetes mellitus associated with risk of macrosomia. Cell Physiol Biochem . 2015;37(1):243–252. doi:10.1159/000430349 26302821
   PubMedGoogle Scholar
• Ding R , Guo F , Zhang Y , et al. Integrated transcriptome sequencing analysis reveals role of miR-138-5p/ TBL1X in placenta from gestational diabetes mellitus. Cell Physiol Biochem . 2018;51(2):630–646. doi:10.1159/000495319 30463081
   PubMedGoogle Scholar
• Yan L , Feng J , Cheng F , et al. Circular RNA expression profiles in placental villi from women with gestational diabetes mellitus. Biochem Biophys Res Commun . 2018;498(4):743–750. doi:10.1016/j.bbrc.2018.03.051 29526755
   PubMed Web of Science ®Google Scholar
• Zhang Y , Qu L , Ni H , et al. Expression and function of lncRNA MALAT1 in gestational diabetes mellitus. Adv Clin Exp Med . 2020;29(8):903–910. doi:10.17219/acem/121524 32783409
   PubMed Web of Science ®Google Scholar
• Wang P , Wang H , Li C , et al. Dysregulation of microRNA-657 influences inflammatory response via targeting interleukin-37 in gestational diabetes mellitus. J Cell Physiol . 2019;234(5):7141–7148. doi:10.1002/jcp.27468 30362558
   PubMed Web of Science ®Google Scholar
• Brett KE , Ferraro ZM , Yockell-Lelievre J , Gruslin A , Adamo KB . Maternal-fetal nutrient transport in pregnancy pathologies: the role of the placenta. Int J Mol Sci . 2014;15(9):16153–16185. doi:10.3390/ijms150916153 25222554
   PubMed Web of Science ®Google Scholar
• Ryan EA , Enns L . Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab . 1988;67(2):341–347. doi:10.1210/jcem-67-2-341 3292560
   PubMed Web of Science ®Google Scholar
• Zhao C , Zhao C , Zhao H . Defective insulin receptor signaling in patients with gestational diabetes is related to dysregulated miR-140 which can be improved by naringenin. Int J Biochem Cell Biol . 2020;128:105824. doi:10.1016/j.biocel.2020.105824 32814161
   PubMed Web of Science ®Google Scholar
• Song TR , Su GD , Chi YL , Wu T , Xu Y , Chen CC . Dysregulated miRNAs contribute to altered placental glucose metabolism in patients with gestational diabetes via targeting GLUT1 and HK2. Placenta . 2021;105:14–22. doi:10.1016/j.placenta.2021.01.015 33517149
   PubMed Web of Science ®Google Scholar
• Peng HY , Li MQ , Li HP . MiR-137 restricts the viability and migration of HTR-8/SVneo cells by downregulating FNDC5 in gestational diabetes mellitus. Curr Mol Med . 2019;19(7):494–505. doi:10.2174/1566524019666190520100422 31109274
   PubMed Web of Science ®Google Scholar
• Muralimanoharan S , Maloyan A , Myatt L . Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: role of miR-143. Clin Sci . 2016;130(11):931–941. doi:10.1042/CS20160076
   PubMed Web of Science ®Google Scholar
• Grygiel-Gorniak B . Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications–a review. Nutr J . 2014;13(1):17. doi:10.1186/1475-2891-13-17 24524207
   PubMed Web of Science ®Google Scholar
• Qiu H , Liu X , Yao S , Zhou J , Zhang X , Du J . Regulation and mechanism of miR-518d through the PPARalpha-mediated NF-kappaB pathway in the development of gestational diabetes mellitus. J Diabetes Res . 2020;2020:7019597. doi:10.1155/2020/7019597 33123597
   PubMed Web of Science ®Google Scholar
• Guan CY , Tian S , Cao JL , Wang XQ , Ma X , Xia HF . Down-regulated miR-21 in gestational diabetes mellitus placenta induces PPAR-alpha to inhibit cell proliferation and infiltration. Diabetes Metab Syndr Obes . 2020;13:3009–3034. doi:10.2147/DMSO.S253920 32943895
   PubMed Web of Science ®Google Scholar
• Zhao C , Zhang T , Shi Z , Ding H , Ling X . MicroRNA-518d regulates PPARalpha protein expression in the placentas of females with gestational diabetes mellitus. Mol Med Rep . 2014;9(6):2085–2090. doi:10.3892/mmr.2014.2058 24639097
   PubMed Web of Science ®Google Scholar
• Wu HH . [Enlightenment coming from HAPO study to HAPO follow-up study]. Zhonghua Yi Xue Za Zhi . 2019;99(34):2646–2649. [ Chinese]31505712
   PubMedGoogle Scholar
• Zeng XC , Liu FQ , Yan R , et al. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/beta-catenin signaling in human hepatocellular carcinoma. Mol Cancer . 2014;13(1):261. doi:10.1186/1476-4598-13-261 25491321
   PubMed Web of Science ®Google Scholar
• Daniele G , Winnier D , Mari A , et al. Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism. Diabetes Care . 2015;38(8):1509–1517. doi:10.2337/dc14-2989 26084344
   PubMed Web of Science ®Google Scholar
• Knofler M , Pollheimer J . Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Front Genet . 2013;4:190. doi:10.3389/fgene.2013.00190 24133501
   PubMedGoogle Scholar
• Forbes K , Westwood M . Maternal growth factor regulation of human placental development and fetal growth. J Endocrinol . 2010;207(1):1–16. doi:10.1677/JOE-10-0174 20817666
   PubMed Web of Science ®Google Scholar
• Zhang J , Chi H , Xiao H , et al. Interleukin 6 (IL-6) and Tumor Necrosis Factor alpha (TNF-alpha) Single Nucleotide Polymorphisms (SNPs), inflammation and metabolism in gestational diabetes mellitus in Inner Mongolia. Med Sci Monit . 2017;23:4149–4157. doi:10.12659/MSM.903565 28846666
   PubMed Web of Science ®Google Scholar
• Li J , Li Y , Zhou X , et al. Upregulation of IL-15 in the placenta alters trophoblasts behavior contributing to gestational diabetes mellitus. Cell Biosci . 2021;11(1):33. doi:10.1186/s13578-021-00533-4 33557944
   PubMed Web of Science ®Google Scholar
• Amirian A , Mahani MB , Abdi F . Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus. Obstet Gynecol Sci . 2020;63(4):407–416. doi:10.5468/ogs.20020 32689769
   PubMedGoogle Scholar
• Schulze F , Wehner J , Kratschmar DV , et al. Inhibition of IL-1beta improves glycaemia in a mouse model for gestational diabetes. Sci Rep . 2020;10(1):3035. doi:10.1038/s41598-020-59701-0 32080229
   PubMed Web of Science ®Google Scholar
• Wei Q , Chen X , Chen H . Association of single nucleotide polymorphisms of the IL-6, IL-10, and TNF-alpha genes with susceptibility to gestational diabetes mellitus. Genet Test Mol Biomarkers . 2020;24(7):390–398. doi:10.1089/gtmb.2020.0069 32513030
   PubMed Web of Science ®Google Scholar
• Piao C , Wang X , Peng S , et al. IL-34 causes inflammation and beta cell apoptosis and dysfunction in gestational diabetes mellitus. Endocr Connect . 2019;8(11):1503–1512. doi:10.1530/EC-19-0436 31648183
   PubMed Web of Science ®Google Scholar
• Yu Z , Liu J , Zhang R , et al. IL-37 and 38 signalling in gestational diabetes. J Reprod Immunol . 2017;124:8–14. doi:10.1016/j.jri.2017.09.011 28992508
   PubMed Web of Science ®Google Scholar
• Schumacher A , Sharkey DJ , Robertson SA , Zenclussen AC . Immune cells at the fetomaternal interface: how the microenvironment modulates immune cells to foster fetal development. J Immunol . 2018;201(2):325–334. doi:10.4049/jimmunol.1800058 29987001
   PubMed Web of Science ®Google Scholar
• Yilmaz O , Kucuk M , Ilgin A , Dagdelen M . Assessment of insulin sensitivity/resistance and their relations with leptin concentrations and anthropometric measures in a pregnant population with and without gestational diabetes mellitus. J Diabetes Complications . 2010;24(2):109–114. doi:10.1016/j.jdiacomp.2009.01.006 19269197
   PubMed Web of Science ®Google Scholar
• Knofler M , Haider S , Saleh L , Pollheimer J , Gamage T , James J . Human placenta and trophoblast development: key molecular mechanisms and model systems. Cell Mol Life Sci . 2019;76(18):3479–3496. doi:10.1007/s00018-019-03104-6 31049600
   PubMed Web of Science ®Google Scholar
• Tong M , Abrahams VM . Immunology of the placenta. Obstet Gynecol Clin North Am . 2020;47(1):49–63. doi:10.1016/j.ogc.2019.10.006 32008671
   PubMed Web of Science ®Google Scholar
• Liu S , Diao L , Huang C , Li Y , Zeng Y , Kwak-Kim JYH . The role of decidual immune cells on human pregnancy. J Reprod Immunol . 2017;124:44–53. doi:10.1016/j.jri.2017.10.045 29055791
   PubMed Web of Science ®Google Scholar
• De Luccia TPB , Pendeloski KPT , Ono E , et al. Unveiling the pathophysiology of gestational diabetes: studies on local and peripheral immune cells. Scand J Immunol . 2020;91(4):e12860. doi:10.1111/sji.12860 31849072
   PubMed Web of Science ®Google Scholar
• Wang X , Xu K , Chen S , Li Y , Li M . Role of interleukin-37 in inflammatory and autoimmune diseases. Iran J Immunol . 2018;15(3):165–174.30246692
   PubMed Web of Science ®Google Scholar
• Zhang H , Luan S , Xiao X , Lin L , Zhao X , Liu X . Silenced microRNA-222 suppresses inflammatory response in gestational diabetes mellitus mice by promoting CXCR4. Life Sci . 2021;266:118850. doi:10.1016/j.lfs.2020.118850 33278386
   PubMed Web of Science ®Google Scholar
• Kircher M , Herhaus P , Schottelius M , et al. CXCR4-directed theranostics in oncology and inflammation. Ann Nucl Med . 2018;32(8):503–511. doi:10.1007/s12149-018-1290-8 30105558
   PubMed Web of Science ®Google Scholar
• Chaleshi V , Asadzadeh Aghdaei H , Nourian M , et al. Association of MALAT1 expression in gastric carcinoma and the significance of its clinicopathologic features in an Iranian patient. Gastroenterol Hepatol Bed Bench . 2021;14(2):108–114.33968337
   PubMedGoogle Scholar
• Onoguchi-Mizutani R , Kirikae Y , Ogura Y , Gutschner T , Diederichs S , Akimitsu N . Identification of a heat-inducible novel nuclear body containing the long noncoding RNA MALAT1. J Cell Sci . 2021;134(10):10. doi:10.1242/jcs.253559
   Web of Science ®Google Scholar
• Abdulle LE , Hao JL , Pant OP , et al. MALAT1 as a diagnostic and therapeutic target in diabetes-related complications: a promising long-noncoding RNA. Int J Med Sci . 2019;16(4):548–555. doi:10.7150/ijms.30097 31171906
   PubMed Web of Science ®Google Scholar
• Onagoruwa OT , Pal G , Ochu C , Ogunwobi OO . Oncogenic role of PVT1 and therapeutic implications. Front Oncol . 2020;10:17. doi:10.3389/fonc.2020.00017 32117705
   PubMed Web of Science ®Google Scholar
• Lu D , Luo P , Wang Q , Ye Y , Wang B . lncRNA PVT1 in cancer: a review and meta-analysis. Clin Chim Acta . 2017;474:1–7. doi:10.1016/j.cca.2017.08.038 28866116
   PubMed Web of Science ®Google Scholar
• Wang Q , Lu X , Li C , et al. Down-regulated long non-coding RNA PVT1 contributes to gestational diabetes mellitus and preeclampsia via regulation of human trophoblast cells. Biomed Pharmacother . 2019;120:109501. doi:10.1016/j.biopha.2019.109501 31627090
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S , Taheri M . Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA. Biomed Pharmacother . 2019;118:109129. doi:10.1016/j.biopha.2019.109129 31326791
   PubMed Web of Science ®Google Scholar
• Wang N , Zhu Y , Xie M , et al. Long noncoding RNA meg3 regulates mafa expression in mouse beta cells by inactivating Rad21, Smc3 or Sin3alpha. Cell Physiol Biochem . 2018;45(5):2031–2043. doi:10.1159/000487983 29529600
   PubMedGoogle Scholar
• Wei GH , Wang X . lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci . 2017;21(17):3850–3856.28975980
   PubMed Web of Science ®Google Scholar
• Zhu X , Wu YB , Zhou J , Kang DM . Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem Biophys Res Commun . 2016;469(2):319–325. doi:10.1016/j.bbrc.2015.11.048 26603935
   PubMed Web of Science ®Google Scholar
• Zhang H . Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus. Exp Ther Med . 2019;18(5):3699–3706.31656536
   PubMed Web of Science ®Google Scholar
• Wang H , She G , Zhou W , Liu K , Miao J , Yu B . Expression profile of circular RNAs in placentas of women with gestational diabetes mellitus. Endocr J . 2019;66(5):431–441. doi:10.1507/endocrj.EJ18-0291 30814439
   PubMed Web of Science ®Google Scholar
• Wang H , Zhou W , She G , Yu B , Sun L . Downregulation of hsa_circ_0005243 induces trophoblast cell dysfunction and inflammation via the beta-catenin and NF-kappaB pathways. Reprod Biol Endocrinol . 2020;18(1):51. doi:10.1186/s12958-020-00612-0 32434530
   PubMed Web of Science ®Google Scholar
• Qi S , Wang X . Decreased expression of miR-185 in serum and placenta of patients with gestational diabetes mellitus. Clin Lab . 2019;65(12):12. doi:10.7754/Clin.Lab.2019.190445
   Web of Science ®Google Scholar
• Zhou X , Xiang C , Zheng X . miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability. Diagn Pathol . 2019;14(1):119. doi:10.1186/s13000-019-0899-9 31653266
   PubMed Web of Science ®Google Scholar
• Zhang L , Zhang T , Sun D , et al. Diagnostic value of dysregulated microribonucleic acids in the placenta and circulating exosomes in gestational diabetes mellitus. J Diabetes Investig . 2021;12(8):1490–1500. doi:10.1111/jdi.13493
   Web of Science ®Google Scholar
• Yu X , Liu Z , Fang J , Qi H . miR-96-5p: a potential diagnostic marker for gestational diabetes mellitus. Medicine . 2021;100(21):e25808. doi:10.1097/MD.0000000000025808 34032694
   PubMed Web of Science ®Google Scholar
• Msheik H , Azar J , El Sabeh M , Abou-Kheir W , Daoud G . HTR-8/SVneo: a model for epithelial to mesenchymal transition in the human placenta. Placenta . 2020;90:90–97. doi:10.1016/j.placenta.2019.12.013 32056558
   PubMed Web of Science ®Google Scholar
• Uren RT , O’Hely M , Iyer S , et al. Disordered clusters of Bak dimers rupture mitochondria during apoptosis. Elife . 2017;6:e19944. doi:10.7554/eLife.19944 28182867
   PubMed Web of Science ®Google Scholar
• Sun DG , Tian S , Zhang L , et al. The miRNA-29b is downregulated in placenta during gestational diabetes mellitus and may alter placenta development by regulating trophoblast migration and invasion through a HIF3A-dependent mechanism. Front Endocrinol (Lausanne) . 2020;11:169. doi:10.3389/fendo.2020.00169 32296392
   PubMed Web of Science ®Google Scholar
• Zhang C , Zhao D . MicroRNA-362-5p promotes the proliferation and inhibits apoptosis of trophoblast cells via targeting glutathione-disulfide reductase. Bioengineered . 2021;12(1):2410–2419. doi:10.1080/21655979.2021.1933678 34107852
   PubMed Web of Science ®Google Scholar
• Stanirowski PJ , Szukiewicz D , Pazura-Turowska M , Sawicki W , Cendrowski K . Placental expression of glucose transporter proteins in pregnancies complicated by gestational and pregestational diabetes mellitus. Can J Diabetes . 2018;42(2):209–217. doi:10.1016/j.jcjd.2017.04.008 28583471
   PubMed Web of Science ®Google Scholar
• Hauguel-de Mouzon S , Shafrir E . Carbohydrate and fat metabolism and related hormonal regulation in normal and diabetic placenta. Placenta . 2001;22(7):619–627. doi:10.1053/plac.2001.0698 11504530
   PubMed Web of Science ®Google Scholar
• Khambule L , George JA . The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. Adv Exp Med Biol . 2019;1134:217–242.30919340
   PubMed Web of Science ®Google Scholar
• Yu J , Zhou Y , Gui J , Li AZ , Su XL , Feng L . Assessment of the number and function of macrophages in the placenta of gestational diabetes mellitus patients. J Huazhong Univ Sci Technolog Med Sci . 2013;33(5):725–729. doi:10.1007/s11596-013-1187-7 24142727
   PubMedGoogle Scholar
• Sisino G , Bouckenooghe T , Aurientis S , Fontaine P , Storme L , Vambergue A . Diabetes during pregnancy influences Hofbauer cells, a subtype of placental macrophages, to acquire a pro-inflammatory phenotype. Biochim Biophys Acta . 2013;1832(12):1959–1968. doi:10.1016/j.bbadis.2013.07.009 23872577
   PubMed Web of Science ®Google Scholar
• Nguyen-Ngo C , Jayabalan N , Salomon C , Lappas M . Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol . 2019;63(3):R51–R72. doi:10.1530/JME-18-0274 31416051
   PubMed Web of Science ®Google Scholar
• Cao JL , Zhang L , Li J , et al. Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus. Sci Rep . 2016;6(1):32268. doi:10.1038/srep32268 27573367
   PubMed Web of Science ®Google Scholar
• Zhao H , Tao S . MiRNA-221 protects islet beta cell function in gestational diabetes mellitus by targeting PAK1. Biochem Biophys Res Commun . 2019;520(1):218–224. doi:10.1016/j.bbrc.2019.09.139 31587871
   PubMed Web of Science ®Google Scholar